Literature DB >> 27722985

QSAR models of antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazoles in various cancer cell lines.

Joanna Matysiak1, Andrzej Niewiadomy2,3.   

Abstract

Imidazo[2,1-b][1,3,4]thiadiazoles have been recognized to possess antiproliferative potency towards a wide spectrum of cancer cell lines. QSAR investigations on a set of 42 di(tri)substituted imidazo[2,1-b][1,3,4]thiadiazoles were carried out to find the descriptors determining their biological potency. Three-variable equations were obtained by combinatorial protocols in multiple linear regression (CP MLR) for all three studied cancer cell lines. They showed that lipophilicity, electronic, and steric factors are decisive for the antiproliferative potency of compounds and indicate the important role of nitrogen atoms of imidazothiadiazole ring in the interactions with the molecular target. The best models gave high r squared values in the range from 0.887 to 0.924. They also have good predictive accuracy confirmed by the high value LOO cross-validation coefficient [Formula: see text] (from 0.842 to 0.904) and by the external validation quantities.

Entities:  

Keywords:  Antiproliferative activity; Imidazothiadiazoles; MLR; QSAR

Mesh:

Substances:

Year:  2016        PMID: 27722985     DOI: 10.1007/s11030-016-9705-8

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  33 in total

1.  Synthesis and QSAR study of the anticancer activity of some novel indane carbocyclic nucleosides.

Authors:  S-W Yao; V H C Lopes; F Fernández; X García-Mera; M Morales; J E Rodríguez-Borges; M N D S Cordeiro
Journal:  Bioorg Med Chem       Date:  2003-11-17       Impact factor: 3.641

2.  Design, synthesis and QSAR studies of dispiroindole derivatives as new antiproliferative agents.

Authors:  Riham F George; Nasser S M Ismail; Jacek Stawinski; Adel S Girgis
Journal:  Eur J Med Chem       Date:  2013-08-11       Impact factor: 6.514

3.  Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents.

Authors:  Subhas S Karki; Kuppusamy Panjamurthy; Sujeet Kumar; Mridula Nambiar; Sureshbabu A Ramareddy; Kishore K Chiruvella; Sathees C Raghavan
Journal:  Eur J Med Chem       Date:  2011-03-04       Impact factor: 6.514

4.  One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.

Authors:  Jurupula Ramprasad; Nagabhushana Nayak; Udayakumar Dalimba; Perumal Yogeeswari; Dharmarajan Sriram
Journal:  Bioorg Med Chem Lett       Date:  2015-08-08       Impact factor: 2.823

5.  2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: synthesis, cytotoxic activity and mechanism of action.

Authors:  Sujeet Kumar; Mahesh Hegde; Vidya Gopalakrishnan; Vinaya Kumar Renuka; Sureshbabu A Ramareddy; Erik De Clercq; Dominique Schols; Anil Kumar Gudibabande Narasimhamurthy; Sathees C Raghavan; Subhas S Karki
Journal:  Eur J Med Chem       Date:  2014-07-17       Impact factor: 6.514

6.  The rm2 metrics and regression through origin approach: reliable and useful validation tools for predictive QSAR models (Commentary on 'Is regression through origin useful in external validation of QSAR models?').

Authors:  Kunal Roy; Supratik Kar
Journal:  Eur J Pharm Sci       Date:  2014-05-29       Impact factor: 4.384

7.  Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions.

Authors:  A K Ghose; G M Crippen
Journal:  J Chem Inf Comput Sci       Date:  1987-02

8.  2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for anticancer agents.

Authors:  Malleshappa N Noolvi; Harun M Patel; Sarita Kamboj; Amandeep Kaur; Vikas Mann
Journal:  Eur J Med Chem       Date:  2012-08-16       Impact factor: 6.514

9.  Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.

Authors:  Sujeet Kumar; Vidya Gopalakrishnan; Mahesh Hegde; Vivek Rana; Sharad S Dhepe; Sureshbabu A Ramareddy; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Mrinal Srivastava; Sathees C Raghavan; Subhas S Karki
Journal:  Bioorg Med Chem Lett       Date:  2014-08-26       Impact factor: 2.823

10.  C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study.

Authors:  Mohammad Saquib; Manish K Gupta; Ram Sagar; Yenamandra S Prabhakar; Arun K Shaw; Rishi Kumar; Prakas R Maulik; Anil N Gaikwad; Sudhir Sinha; Anil K Srivastava; Vinita Chaturvedi; Ranjana Srivastava; Brahm S Srivastava
Journal:  J Med Chem       Date:  2007-06-02       Impact factor: 7.446

View more
  3 in total

1.  Antitumor evaluation and 3D-QSAR studies of a new series of the spiropyrroloquinoline isoindolinone/aza-isoindolinone derivatives by comparative molecular field analysis (CoMFA).

Authors:  Masoud Sadeghzadeh; Maryam Salahinejad; Nahid Zarezadeh; Mehdi Ghandi; Maryam Keshavarz Baghery
Journal:  Mol Divers       Date:  2017-08-23       Impact factor: 2.943

2.  Virtual screening of PEBP1 inhibitors by combining 2D/3D-QSAR analysis, hologram QSAR, homology modeling, molecular docking analysis, and molecular dynamic simulations.

Authors:  Mourad Stitou; Hamid Toufik; Taoufik Akabli; Fatima Lamchouri
Journal:  J Mol Model       Date:  2022-05-12       Impact factor: 1.810

3.  [Design and synthesis of imidazo-fused heterocycles derivatives and their anti-tumor activity against breast cancer in mice].

Authors:  Jin Zhou; Bohong Liao; Yinggui Deng; Xiaowen Guo; Jialan Zhao; Jie Sun; Zhibo Zhu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.